Rankings / Hormones & Endocrine
GnRH/LH-axis analogs for testosterone stimulation
Hormones & Endocrine · HPG-axis peptide / gonadotropin manipulation
Tier C
High-risk evidence profile
Bottom line
Read Off Label grades GnRH/LH-axis analogs for testosterone stimulation as C (4.9/10) based on moderate evidence, med benefit magnitude, and a med-high-risk safety profile.
Its high-risk evidence profile reflects a Safety score of 3.5/10; reported benefits and harms can differ by indication, dose, route, duration, and population.
WADA coverage: chorionic gonadotrophin/CG, luteinizing hormone/LH, gonadotrophin-releasing hormone/GnRH/gonadorelin, buserelin, deslorelin, goserelin, histrelin, leuprorelin, nafarelin, triptorelin, kisspeptin and agonist analogues.
Studied, labeled, or reported-use context: Clinical fertility/endocrine protocols vary; no healthy optimization dose — Rx/clinical peptide context; WADA S2 prohibited in males; not individualized guidance.
What the evidence says
WADA coverage: chorionic gonadotrophin/CG, luteinizing hormone/LH, gonadotrophin-releasing hormone/GnRH/gonadorelin, buserelin, deslorelin, goserelin, histrelin, leuprorelin, nafarelin, triptorelin, kisspeptin and agonist analogues. Existing rows cover HCG, gonadorelin and kisspeptin-10; this row captures the broader WADA class and spelling aliases such as gonadotrophin and clomifene-style nomenclature. Additional WADA alias coverage: Kisspeptin and its agonist analogues.
Mechanism
LH and GnRH analogs can stimulate or suppress gonadal steroid production depending pattern and context; male enhancement use targets endogenous testosterone signaling.
Studied, labeled, or reported dose & route
Clinical fertility/endocrine protocols vary; no healthy optimization dose
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about GnRH/LH-axis analogs for testosterone stimulation's effects?
- Read Off Label rates the evidence for GnRH/LH-axis analogs for testosterone stimulation as Moderate and the benefit magnitude as med, producing an overall grade of C (4.9/10). WADA coverage: chorionic gonadotrophin/CG, luteinizing hormone/LH, gonadotrophin-releasing hormone/GnRH/gonadorelin, buserelin, deslorelin, goserelin, histrelin, leuprorelin, nafarelin, triptorelin, kisspeptin and agonist analogues.
- What safety findings are reported for GnRH/LH-axis analogs for testosterone stimulation?
- GnRH/LH-axis analogs for testosterone stimulation has a med-high risk profile in the database. Med-High (axis suppression/desensitization, fertility effects, mood/libido changes, injection/protocol risk) Legal status: Rx/clinical peptide context; WADA S2 prohibited in males.
- What does the low Safety score for GnRH/LH-axis analogs for testosterone stimulation represent?
- The Safety score is 3.5/10. It records the substantial harms described for one or more use contexts; the Benefit score, indication, dose, route, duration, population, and legal status remain separate parts of the evidence profile.
- What doses or routes are reported for GnRH/LH-axis analogs for testosterone stimulation?
- Clinical fertility/endocrine protocols vary; no healthy optimization dose This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does GnRH/LH-axis analogs for testosterone stimulation work?
- LH and GnRH analogs can stimulate or suppress gonadal steroid production depending pattern and context; male enhancement use targets endogenous testosterone signaling.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.